Novaflow
- Company typePrivate
- Founded2025
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
Novaflow firmographics
Firmographics- Name
- Novaflow
- Legal name
- Novaflow
- Website
- https://novaflowapp.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Novaflow industry classification
Industry- Product category
- Bioinformatics Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
- akta.pro secondary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
Keywords
Where Novaflow is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
Novaflow business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- SaaS Subscription (Tiered Plans): Tiered subscription model with Free (Basic), Unlimited (Custom pricing), and Enterprise tiers. Revenue generated from monthly/annual subscriptions with increasing feature access and user limits at each tier.
- Freemium Entry Tier: Free basic tier provides limited usage (10 prompts per chat) to attract solo researchers and students, with conversion pathway to paid unlimited and enterprise plans.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free tier for solo researchers and students |
| Subscription | Annual | Unlimited access for academic labs and research teams |
| Subscription | Annual | Enterprise tier for biotech, pharma, and institutional research |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Novaflow product offering
Product offeringCore offering
Novaflow is an AI-powered bioinformatics analysis platform that automates data analysis for life science researchers. Using a natural language interface backed by large language models, it executes validated peer-reviewed workflows (RNA-seq, ATAC-seq) and produces publication-ready figures and traceable results, eliminating manual scripting and reducing analysis turnaround from weeks to minutes.
Differentiator
Problem solved
Functional benefit
Products and services
- Novaflow AI-powered bioinformatics analysis platform that automates data analysis for life science researchers, transforming raw experimental data into publication-ready results in minutes using natural language prompts and validated peer-reviewed workflows such as RNA-seq and ATAC-seq. Built for solo researchers, academic labs, and biotech/pharma enterprises.
Quantifiable outcome
- Reduces analysis turnaround from 3 weeks to under 30 minutes
- +2 more outcomes
Companies that use Novaflow
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Novaflow technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
Novaflow partnerships and signals
Strategic signalScale indicators3 records
Novaflow competitors and assessment
Company assessmentEmerging players
- Insitro: AI/ML-driven drug discovery platform combining biology and machine learning. Comparable as an emerging player applying ML to life sciences workflows, though focused on drug discovery rather than general bioinformatics automation.
- Parse Biosciences: Provider of single-cell sequencing kits and analysis software for biological research. Adjacent emerging player in the multi-omics analysis space with partial workflow overlap.
Direct peers
- Benchling: Cloud platform for life science R&D combining electronic lab notebooks, inventory, and bioinformatics workflows. Directly comparable as an informatics layer for biologists that Novaflow's natural-language analysis competes with and could integrate alongside.
- DNAnexus: Cloud-based genomics and bioinformatics analysis platform serving pharma, biotech, and academic researchers. Directly comparable as a managed environment for running reproducible multi-omics pipelines at enterprise scale.
- Geneious: Desktop and cloud bioinformatics software used by biologists for DNA/RNA sequence analysis. Directly comparable as a biologist-friendly analysis tool that Novaflow competes with through its no-code, conversational UX.
Broad incumbents
- Ginkgo Bioworks: Synthetic biology platform with significant bioinformatics infrastructure for organism engineering. Broad incumbent operating at the intersection of AI/ML and life science workflows relevant to Novaflow's customer base.
- Dotmatics: Enterprise scientific R&D informatics platform spanning discovery, biology, and chemistry. Broader incumbent with overlapping bioinformatics capabilities but a much wider portfolio than Novaflow's analysis-only focus.
- QIAGEN (Digital Insights / Rosalind): QIAGEN's Digital Insights unit (including the Rosalind platform) provides bioinformatics analysis for genomics and multi-omics. Comparable as an established bioinformatics analysis offering targeting both academic and clinical customers.
Market position
Customer concentration
Novaflow financial estimates
Financial estimateRevenue estimate
Valuation estimate
Novaflow leadership team
Management profileNumber of profiles
Profiles2 records
Novaflow funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Novaflow M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Novaflow
What does Novaflow do?
Novaflow is an AI-powered bioinformatics analysis platform that automates data analysis for life science researchers. Using a natural language interface backed by large language models, it executes validated peer-reviewed workflows (RNA-seq, ATAC-seq) and produces publication-ready figures and traceable results, eliminating manual scripting and reducing analysis turnaround from weeks to minutes.
When was Novaflow founded?
Novaflow was founded in 2025. It employs 1 to 10 people.
Where is Novaflow based?
Novaflow is headquartered in San Francisco, United States, in the North America region.
How does Novaflow make money?
Two revenue lines are on record. SaaS Subscription (Tiered Plans) is the primary driver. The others are freemium Entry Tier.
Who are Novaflow's main competitors?
Emerging players on record are Insitro and Parse Biosciences. Direct peers are Benchling, DNAnexus and Geneious. Broad incumbents are Ginkgo Bioworks, Dotmatics and QIAGEN (Digital Insights / Rosalind).
Does Novaflow have an API?
No public API is recorded for Novaflow.
What industry is Novaflow in?
Novaflow's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGAJAD, Bioinformatics & Multi-omics Analysis Software. Its NAICS code is 513210 and its SIC code is 7372.